On this page you will find links to meetings, workshops, and other events relevant to cancer research policy. This page is intended to serve as a resource for members of the AACR and the cancer community; events listed are not necessarily endorsed by the AACR.
To suggest events for this calendar, please send information to govrelations@aacr.org.
Last Updated: March 15, 2010
NIH Conference, “Science of Dissemination and Implementation: Methods and Measurement”
This conference will provide a forum to facilitate growth in the science of dissemination and implementation to help close the gap between research evidence and clinical and public health practice.
Date: March 15-16, 2010
Location: NCI, Bethesda, MD
Meeting of the CDC Breast and Cervical Cancer Early Detection and Control Advisory Committee
This meeting will examine the U.S. Preventive Services Task Force guidelines for breast and cervical cancer screening and the revised clinical screening recommendations for breast and cervical cancer.
Date: March 15-17, 2010
Location: CDC, Atlanta, GA
Research!America National Forum, “Invest in Tomorrow. Invest in Research”
This forum will feature discussion among nationally recognized leaders in health research. There will be two discussions and a question-and-answer session. The focus will be on the role of research in the economy and the as the country emerges from the economic recession and our leaders prioritize limited resources.
Date: March 16, 2010
Time: Noon
Location: National Press Club, Washington, DC
Research!America Advocacy Awards Dinner
The annual Research!America Advocacy Awards Program was established in 1996 by the board of directors to honor outstanding advocates for medical, health and scientific research.
Date: March 16, 2010
Time: 6:30 p.m.
Location: Andrew W. Mellon Auditorium, Washington, DC
Meeting of the HHS Health Information Technology (HIT) Policy Committee
The committee will hear reports from its work groups, including the Meaningful Use Workgroup, the Certification/Adoption Workgroup, the NHIN Workgroup, the Privacy & Security Policy Workgroup, and the Strategic Plan Workgroup.
Date: March 17, 2010
Location: Omni Shoreham Hotel, Washington, DC
Meeting of the FDA Pharmaceutical Science and Clinical Pharmacology Advisory Committee
In this meeting, the committee will discuss and provide comments on general issues related to the application of pharmacogenomics in early drug development as well as the implementation of a patient-centric approach to drug safety and recent developments in transporter-mediated drug interactions.
Date: March 17, 2010
Location: Marriott Marquis, Atlanta, GA
National Colorectal Cancer Roundtable (NCCRT) Briefing, “Developing a National Colorectal Cancer Screening Program: Saving Money, Saving Lives”
This briefing will discuss the importance of colorectal cancer screenings and the barriers that many face in receiving these lifesaving services. Emphasis will be placed on prevention and early detection. Invited speakers include Reps. Kay Granger (R-Texas) and Kathy Dahlkemper (D-Penn.).
Date: March 17, 2010
Time: 10 a.m.
Location: 122 Cannon HOB, Washington, DC
Meeting of the NIH Advisory Board for Clinical Research
The primary purpose of this meeting is to review the FY2011 Clinical Center Budget.
Date: March 22, 2010
Time: 10 a.m.
Location: NIH, Bethesda, MD
Meeting of the FDA Oncologic Drugs Advisory Committee
The committee will discuss new drug application (NDA) 022-481, proposed trade name PIXUVRI (pixantrone dimaleate) injection, manufactured by Cell Therapeutics, Inc and NDA 022-374, proposed trade name OMAPRO (omacetaxine mepesuccinate) for injection, manufactured by ChemGenex Pharmaceuticals. The first product is billed as a single agent treatment for patients with recurring or refractory (difficult to treat), aggressive non-Hodgkin’s lymphoma who have not responded to other lines of therapy. The proposed use for the second product is for the treatment chronic myeloid leukemia bearing a genetic alteration known as the Bcr-Abl T315I mutation who have not been responsive to other lines of therapy.
Date: March 22, 2010
Time: 8 a.m.
Location: The Hilton, Washington, DC
National Committee for Quality Assurance (NCQA) 2010 Quality Health Awards
This program will honor the achievements of individuals and organizations that highlight the need for and drive health care quality improvement.
Date: March 23, 2010
Location: Andrew W. Mellon Auditorium, Washington, DC
Meeting of the NIH Advisory Committee on Research on Women's Health
The participants of this meeting will provide advice to the ORWH on research activities related to women’s health and related studies to be undertaken by the NIH. The agenda also cites an introduction of the office mandates and discussion of scientific issues.
Date: March 23, 2010
Time: 9 a.m.
Location: NIH, Bethesda, MD
Meeting of the HHS Health Information Technology (HIT) Standards Committee
In this meeting, the Committee will provide recommendations to the National Coordinator on standards, implementation specifications, and certification criteria for the electronic exchange and use of health information for purposes of adoption, consistent with the implementation of the Federal Health IT Strategic Plan, and in accordance with policies developed by the HIT Policy Committee.
Date: March 24, 2010
Location: Omni Shoreham Hotel, Washington, DC
3rd Annual Biospecimen Research Network (BRN) Symposium, "Advancing Cancer Research through Biospecimen Science"
The symposium will address the significant impact of pre-analytical biospecimen variables on cancer research and molecular medicine. It will bring together leaders in the fields of biospecimen research, genomics, proteomics, oncology, pathology, biobanking, hospital administration and pharmaceutics as well as patient advocates.
Date: March 24-25, 2010
Location: Marriott Hotel, Bethesda, MD
Meeting of the NCI Director’s Consumer Liaison Group
This meeting will include an examination of The Cancer Genome Atlas, reports of the DCLG Genomics Working Group, NCI Professional Judgment Budget, NCI Director's update, and a discussion on how to engage the community around genomics research.
Date: March 24-26, 2010
Location: NCI, Bethesda, MD
Meeting of the FDA Medical Devices Advisory Committee, “Risks from Exposure to Ultraviolet Radiation from Tanning Lamps”
The committee will review and discuss recent information regarding the possible risks to the general public from intentional exposure to ultraviolet radiation (UV) from use of tanning lamps. The committee will be asked to recommend whether changes to current classification or current regulatory controls of UV emitting devices (lamps) used for tanning are needed.
Date: March 25, 2010
Time: 8 a.m.
Location: The Hilton, Gaithersburg, MD
FDA Meeting on Device Improvements to Reduce Unnecessary Radiation Exposure from Medical Imaging
This meeting will discuss possible steps that could be taken by manufacturers of devices used in computed tomography (CT) and in fluoroscopy to reduce unnecessary exposure to ionizing radiation during CT and fluoroscopic procedures.
Date: March 30-31, 2010
Location: Holiday Inn, Gaithersburg, MD
Meeting of the FDA Tobacco Products Scientific Advisory Committee
This meeting will include an overview of the FDA Center for Tobacco Products, the Family Smoking Prevention and Tobacco Control Act (the Tobacco Control Act), the Tobacco Products Scientific Advisory Committee and receive presentations on menthol as it relates to the demographics of users, preferential use by persons initiating tobacco use, the effects of menthol on addiction and cessation, marketing and consumer perceptions about menthol cigarettes, the sensory qualities of menthol cigarettes, and the effects of menthol on how cigarettes are smoked. The second day of the meeting will continue with presentations as well as a discussion of topics for future meetings.
Date: March 30-31, 2010
Location: National Transportation Safety Board (NTSB) Conference Center, Washington, DC
Meeting of the Secretary's Advisory Committee on National Health Promotion and Disease Prevention, "Objectives for 2020"
This meeting will include Committee discussion, as well as an opportunity for members of the public to submit written and oral comments.
Date: April 1, 2010
Time: 2 p.m.
Location: Accessible via WebEx software
Meeting of the HHS Advisory Committee on Minority Health, Eliminating Health Disparities
This meeting will discuss ways to improve the health of racial and ethnic minority populations through the development of health policies and programs that will help eliminate health disparities. There will also be a public comment session.
Date: April 6-7, 2010
Location: Doubletree Hotel, Washington, DC
Meeting of the FDA Pharmaceutical Science and Clinical Pharmacology Advisory Committee
This meeting will include presentations from the Office of Generic Drugs (OGD) and a discussion of two bioequivalence (BE) topics relevant to generic drug approval: (1) revising the BE approaches for critical dose drugs; and (2) the use of partial area under the curve (AUC) for the evaluation of abbreviated new drug applications (ANDAs) for products with complex pharmacokinetic profiles.
Date: April 13, 2010
Location: Hilton, Silver Spring, MD
AACR 101st Annual Meeting 2010, "Conquering Cancer Through Discovery Research"
AACR 101st Annual Meeting 2010 will highlight the best cancer science and medicine from institutions all over the world. The meeting will take advantage of its setting in Washington, DC, to feature a number of policy presentations related to cancer research. Registration and abstract submission now open.
Date: April 17-21, 2010
Location: Washington, DC
Meeting of the Medicare Evidence Development and Coverage Advisory Committee
This meeting will offer advice and recommendations concerning the scientific evidence needed to determine if medical items and services should be covered under the Medicare statute. The focus will be on currently available evidence on the outcomes of radiation therapy for the treatment of localized prostate cancer.
Date: April 21, 2010
Location: Centers for Medicare and Medicaid Services, Baltimore, MD
NCI International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies
This conference will feature presentations on recent advances in areas such as viral oncology, immunology, genetics, epidemiology, pathogenesis, early diagnosis and clinical investigation of malignant diseases associated with HIV and other acquired immunodeficiency states. The ICMAOI is designed to facilitate the exchange of information between laboratory and clinical investigators to accelerate the translation of basic scientific discoveries into clinical applications.
Date: April 26-27, 2010
Location: NIH, Bethesda, MD
42nd Congress of the International Society of Paediatric Oncology (SIOP)
Dana-Farber/Children's Hospital Cancer Care will host the SIOP 42nd Annual Congress, recognized as the most relevant educational meeting for those involved in various fields of pediatric oncology. The meeting will include scientific symposia, internationally known keynote speakers, abstract presentations, poster sessions, and day-long state of the art program. This the first time in 17 years that SIOP is taking place in the United States.
Date: October 21-24, 2010
Location: Boston, MA
Additional meeting and event information:
Top